购物车
- 全部删除
- 您的购物车当前为空
Trabodenoson (INO-8875) 是一种具有选择性和有效性的的腺苷 A1 受体激动剂,是一种腺苷类似物,可用于研究原发性开角型青光眼。
为众多的药物研发团队赋能,
让新药发现更简单!
Trabodenoson (INO-8875) 是一种具有选择性和有效性的的腺苷 A1 受体激动剂,是一种腺苷类似物,可用于研究原发性开角型青光眼。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,290 | 现货 | |
2 mg | ¥ 1,930 | 现货 | |
5 mg | ¥ 3,290 | 现货 | |
10 mg | ¥ 4,730 | 现货 | |
25 mg | ¥ 7,260 | 现货 | |
50 mg | ¥ 9,790 | 现货 | |
100 mg | ¥ 13,200 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 3,650 | 现货 |
产品描述 | Trabodenoson (INO-8875) is a selective and potent adenosine A1 receptor agonist, an adenosine analog, for the study of primary open-angle glaucoma. |
体外活性 | Treatment with Trabodenoson significantly increases MMP-2 activity and MMP-14 abundance, while decreasing expression of fibronectin and collagen IV[2]. |
体内活性 | Trabodenoson (6.0%) demonstrates an average IOP drop of 2.45 ± 0.38 mm Hg in young mice over 7 days (downregulation)[2]. In induced eyes, topical trabodenoson significantly upregulates nestin expression in the ONH compared with vehicle-treated non-induced eyes[1]. Trabodenoson-treated eyes show significantly reduced optic nerve (ON) edema compared with vehicle-treated eyes. Additionally, RGC counts are higher in Trabodenoson-treated eyes compared to vehicle, accounting for 74% versus 47% of the contralateral eye[1]. |
别名 | INNO-8875, 曲波迪松, INO-8875, PJ875, PJ-875, INNO 8875, INNO8875, PJ 875 |
分子量 | 380.36 |
分子式 | C15H20N6O6 |
CAS No. | 871108-05-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (262.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.